Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 December 2019 | Story Dr Cindé Greyling | Photo Supplied
When academics and economics meet

KovsieInnovation at the UFS is bridging the gap between industry and academics with a powerful force. For too long, research remained an academic pursuit, with many innovative ideas stuck between the pages of a thesis – only to come alive during exclusive, short-lived conference proceeds.


KovsieInnovation

Recently, Gerard Verhoef, Director in the Directorate: Research Development (DRD), and his team from KovsieInnovation finalised their Innovation and Commercialisation Strategy in order to create a structured pathway for good ideas. The primary objective of KovsieInnovation – the UFS Innovation and Entrepreneurship Office – is to achieve sustainable growth in third-stream income from innovative research activities stemming from the UFS. “Potential successful ideas must be feasible, viable, and sustainable, and we formulated an eight-step plan to facilitate this,” Verhoef explains. Ultimately, the DRD wants to attract new and continuous research as a renowned academic knowledge partner that can foster, drive, and successfully commercialise innovative research activities; and in doing so, foster an entrepreneurial culture at the UFS.


Liquid Culture

One such success story is the development of Liquid Culture into a business of choice, supplying liquid yeast to breweries and bakeries. Christopher Rothmann and Dr Errol Cason are the driving forces behind this company that produces their sought-after and stable yeast product in the Department of Microbiology, Biochemistry and Food Biotechnology at the UFS. With world-class equipment and laboratories, they house one of the largest yeast-culture collections in the world.

Both Rothman and Dr Cason were home brewers for many years before starting to produce commercial batches. They believe it would not have been possible without the help of KovsieInnovation. This project was also one of the finalists in the National Entrepreneurship Intervarsity.


Christo Strydom Nutrition (CSN)

Another innovative way in which the UFS generates third-stream income via the DRD, is by partnering with already successful commercial products. One such example is the recent successful royalty agreement with CSN. With this transaction, the university unlocked its brand potential to the benefit of both the industry partner and the UFS. Quality assurance remains the key success factor for deals like this.

News Archive

Doctors make history with unique heart operation
2012-04-04

 

Cardiologists at the university delivered the first Melody pulmonary valve in Africa.
Photo: Evert Kleynhans
30 March 2012

Academics of the Faculty of Health Sciences at the University of the Free State made history in Africa once again this week with the implant of a special pulmonary heart valve.

“Today we are extremely proud Free State citizens,” Prof. Stephen Brown and Dr. Danie Buys from the UFS Department of Paediatrics and Child Health said after they placed the Medtronic Melody pulmonary valve in two young patients at the Universitas hospital in Bloemfontein.

This is the first time in Africa that the Melody valve is placed.

To date there are currently only 3 000 of these valves place in the world.

“It feels incredible to be part of a team of experts from the faculty.”

The Medtronic Melody valve is delivered percutaneously through a catheter from the groin. This operation is for children and young adults who are born with a malformation of their pulmonary valve.

These children often require open-heart surgery at a very young age and later require additional open-heart surgeries to restore blood flow between the heart and the lungs.

Prof. Brown said that of all congenital diseases, heart disease is most common. A lot of children born with heart disease are diagnosed very late and many die without ever receiving specialised care.

In 2011, Prof. Brown and two other cardiologists from the UFS, Prof. Hennie Theron en Dr JP Theron also reached a medical milestone when they were the first cardiologists in South Africa to do a second generation Medtronic CoreValve implant on an elderly patient.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept